You are currently viewing Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Cholera Vaccine-Simplified

Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Cholera Vaccine-Simplified

Project Summary

This is a multicenter, randomized, observer-blinded, controlled study to evaluate immune non-inferiority and safety of OCV-S compared to Shanchol™ in 1 to 40 years old healthy Nepalese participants with the study period of 13 months duration. The sites involved are Kanti Children’s Hospital, Dhulikhel Hospital, Kathmandu University Hospital,  B. P. Koirala Institute of Health Sciences, and Nepalgunj Medical College.

Objectives

Primary objectives:

  1. To demonstrate non-inferiority of OCV-S compared to Shancholâ„¢ as measured by seroconversion rates of anti-V. cholerae O1 Inaba and anti-V. cholerae O1 Ogawa vibriocidal titer 2 weeks after second dose for all ages (i.e., one lot of OCV-S)
  2. Assess and compare safety profile in all age strata combined and describe the safety profile in each age stratum 7 days and 28 days after each dose

Secondary objectives:

  1. To demonstrate non-inferiority of OCV-S compared to Shancholâ„¢ as measured by GMT of vibriocidal titers against V. cholerae O1 Inaba and V. cholerae O1 Ogawa 2 weeks after second dose (i.e., one lot of OCV-S) for all ages
  2. To demonstrate non-inferiority of OCV-S compared to Shancholâ„¢ as measured by seroconversion rates of vibriocidal titers against V. cholerae O1 Inaba and V. cholerae O1 Ogawa 2 weeks after second dose (i.e., one lot of OCV-S) in each age stratum
  3. To demonstrate non-inferiority of OCV-S compared to Shancholâ„¢ as measured by GMT of vibriocidal titers against V. cholerae O1 Inaba and V. cholerae O1 Ogawa at 2 weeks after second dose (i.e., one lot of OCV-S) in each age stratum
  4. To demonstrate the equivalence of immunogenicity as measured by GMT of vibriocidal titers against V. cholerae O1 Inaba and V. cholerae O1 Ogawa of 3 lots of OCV-S 2 weeks after second dose in adults

Team Members

 

Principal Investigator(s): Prof. Dr. Rajeev Shrestha, Dr. Dipesh Tamrakar

Co-Investigator(s): Dr. Srijana Dangol, Dr. Ashish Shrestha, Dr. Sameera Thapa, Dr. Samita Adhikary, Dr. Shristi Jonchhe, Dr. Pranodan Poudel, Dr. Surendra Kumar Madhup, Dr. Manish Neupane, Dr. Puspanjali Adhikary

For more detailed Information, Please contact:  rajeev.shrestha@kusms.edu.np or dipesht@kusms.edu.np